Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy

Ruijin Hospital, Jiaotong University School of Medicine, Yuanyang Subdivision, Shanghai 200025, China.
Zhonghua yi xue za zhi 09/2010; 90(35):2473-6.
Source: PubMed


To evaluate the efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy with regards to sensory symptoms and nerve conduction velocity.
A total of 236 diabetics with symptomatic polyneuropathy were enrolled into this 5-center, randomized, double-blind and placebo-controlled study of α-lipoic acid 1800 mg daily (n = 117) or matching placebo (n = 119) for 12 weeks. The primary outcome was total symptom score (TSS). Secondary end points included nerve conduction velocity, individual symptom score, HbA1c and safety parameters. The above parameters were reviewed and recorded at zero point and after treatment for 2, 4, 8, 12 weeks separately.
73.27% patients with symptomatic polyneuropathy improved after treatment with α-lipoic acid for 12 weeks versus 18.27% with placebo. TSS declined by 2.6 ± 2.3 with α-lipoic acid. And it was more than 0.7 ± 1.4 versus placebo (P < 0.05). TSS decreased quickly after treatment with α-lipoic acid for 2 weeks (P < 0.05). And it was better than placebo. Individual symptom scores of pain, extremity numbness, burning sensation or resting abnormal sensations were significantly diminished as compared to those before treatment and placebo group (all P < 0.05). Nerve conduction velocity had no change. HbA1c further decreased at the end of trial after α-lipoic acid treatment (P < 0.05). The incidence rates of adverse effects were 25.4% vs 11.8% in the treatment and control groups. The major manifestation was burning sensation from throat to stomach (12.7%).
Oral treatment with high-dose α-lipoic acid for 12 weeks may improve symptoms in patients with diabetic polyneuropathy. Dose of 600 mg thrice daily for 2 weeks has marked effects with a reasonable safety.

32 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MANY FUNCTIONS have been ascril)ed to platelets. Johnson and Seegers' list eleven so-called platekt factors related to clotting. The general be- lief is that these factors are contained in the platelet structure as derived from the megakaryocyte. However, since Roskam's2 classic description of the "atmosphere plasmatique" of the platelet, a large number of articles in the coagulation literature give evidence that many of the platelet activities are derived from materials adsorbed onto the platelet surface from the plasma. The purpose of this paper is to summarize this evidence. Our viewpoint is admit- tedly a biased one in favor of the concept that the ability of the platelet to act as a sponge is a basic function. We believe that the platelet adsorbs and con- centrates coagulation and other factors and carries them through the circula- tion. �Vhen a vessel wall is ruptured, the platelet is attracted to the site of in- jury. Once there, the adsorbed proteins and calcium are somehow triggered to produce platelet clumping followed by viscous metamorphosis. In the small vessels this process is sufficient to stop the flow of l)lood. In the larger vessels hemostasis does not occur until the process continues to fibrin formation. The platelet surface thus serves as the link relating platelet agglutination and small vessel hemostasis to coagulation. This theory is in contrast to the generally ac- cepted concept that hemostasis in arterioles and venules is a thing apart from l)loOd coagulation.34 The concept of the platelet as a sponge had its beginnings with Roskam's work in 1922.2 He has reiterated his concept through the years,5'6 and has pointed out the close relationship between platelet adhesiveness, clumping and viscous metamorphosis. These processes are all dependent on the preservation of the plasma coating on the platelet surface. Bounameaux7'8 has demonstrated that without this coating, or by modifying this coating, platelet adhesiveness and clumping are lost. He has also pointed out that those factors on the plate- let surface which are necessary for platelet adhesiveness are the same factors which are necessary for blood clotting. L#{252}scher,4541' like Bounameaux, pictures viscous metamorphosis as occurring when thrombin is generated on the plate- let surface. In L#{252}scher's scheme, this thrombin unites with a plasma cofactor and calcium to initiate viscous metamorphosis. A protein which he calls "pro- tein-S" is then extruded from the platelet. This protein, like fibrinogen, clots under the influence of thrombin. The protein-S clot then spontaneously retracts and is responsible for the firmness of the platelet aggregates and for the sub- sequent clot retraction. The entire process is quite similar to coagulation, except
    Blood 07/1961; 17:767-74. · 10.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes mellitus is a multi-faceted metabolic disorder where there is increased oxidative stress that contributes to the pathogenesis of this debilitating disease. This has prompted several investigations into the use of antioxidants as a complementary therapeutic approach. Alpha lipoic acid, a naturally occurring dithiol compound which plays an essential role in mitochondrial bioenergetic reactions, has gained considerable attention as an antioxidant for use in managing diabetic complications. Lipoic acid quenches reactive oxygen species, chelates metal ions, and reduces the oxidized forms of other antioxidants such as vitamin C, vitamin E, and glutathione. It also boosts antioxidant defense system through Nrf-2-mediated antioxidant gene expression and by modulation of peroxisome proliferator activated receptors-regulated genes. ALA inhibits nuclear factor kappa B and activates AMPK in skeletal muscles, which in turn have a plethora of metabolic consequences. These diverse actions suggest that lipoic acid acts by multiple mechanisms, many of which have only been uncovered recently. In this review we briefly summarize the known biochemical properties of lipoic acid and then discussed the oxidative mechanisms implicated in diabetic complications and the mechanisms by which lipoic acid may ameliorate these reactions. The findings of some of the clinical trials in which lipoic acid administration has been tested in diabetic patients during the last 10 years are summarized. It appears that the clearest benefit of lipoic acid supplementation is in patients with diabetic neuropathy.
    Frontiers in Pharmacology 11/2011; 2:69. DOI:10.3389/fphar.2011.00069 · 3.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We have previously demonstrated that the administration of low doses of dimethoate, glyphosate and zineb to rats (i.p. 1/250 LD50, three times a week for 5weeks) provokes severe oxidative stress (OS) in specific brain regions: substantia nigra, cortex and hippocampus. These effects were also observed in plasma. Lipoic acid (LA) is considered an "ideal antioxidant" due to its ability to scavenge reactive species, reset antioxidant levels and cross the blood-brain barrier. To investigate its protective effect we administered LA (i.p. 25, 50 and 100mg/kg) simultaneously with the pesticide mixture (PM) for 5weeks. After suppression of PM administration, we evaluated the restorative effect of LA for a further 5weeks. LA prevented OS and the production of nitrites+nitrates [NOx] caused by PM in a dose-dependent manner. The PM-induced decrease in reduced glutathione and α-tocopherol levels in all brain regions was completely restored by LA at both high doses. PM administration also caused an increase in prostaglandins E(2) and F(2α) in brain that was reduced by LA in a dose-dependent fashion. Taking into account the relationship between OS, inflammation and apoptosis, we measured caspase and calpain activity. Only milli- and micro-calpain isoforms were increased in the PM-treated group and LA reduced the activities to basal levels. We also demonstrated that interrupting PM administration is not enough to restore the levels of all the parameters measured and that LA is necessary to achieve basal status. In our experimental model LA displayed a protective role against pesticide-induced damage, suggesting that LA administration is a promising therapeutic strategy to cope with disorders suspected to be caused by OS generators, especially in brain.
    Neurochemistry International 09/2012; 61(7). DOI:10.1016/j.neuint.2012.09.003 · 3.09 Impact Factor
Show more